The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
csl | 705 |
csl behring | 54 |
b-creative sweden | 27 |
pfizer | 18 |
merck & company | 13 |
csl behring recombinant facility | 11 |
coley pharmaceutical group | 9 |
csl (dualcom) | 4 |
cls | 3 |
walter & eliza hall inst of medica… 🛈 | 2 |
csl | 66 |
csl behring | 10 |
csl behring recombinant facility | 9 |
b-creative sweden | 5 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
a reconstituted high density lipoprotein formulation and production method thereof | 29 | 2010 |
high affinity antibody antagonists of interleukin-13 receptor alpha 1 | 28 | 2006 |
humanized anti-interleukin 3 receptor alpha chain antibodies | 27 | 2010 |
porphorymonas gingivalis polypeptides and polynucleotides | 25 | 1997 |
reconstituted hdl formulation | 25 | 2012 |
inhibitory anti-factor xii/xiia monoclonal antibodies and their uses | 25 | 2011 |
antibodies against g-csfr and uses thereof | 24 | 2011 |
immunogenic lhrh compositions and methods relating thereto | 23 | 1997 |
process for preparing apolipoprotein a-i (apo a-i) | 22 | 2013 |
dosage regime for apolipoprotein formulations | 22 | 2011 |